SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : sciclone pharmaceuticals
SCLN 11.150.0%Oct 20 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Skywatcher who wrote (415)2/15/2000 3:45:00 PM
From: 5handicap  Read Replies (1) of 1137
 
Hi Chris,

I tend to believe that the sell off didn't have much to do with the press release today. After all it won't it be 2 years minimum before any CPX revenue shows up? Zadaxin has been driving the stock price and will for the forseeable future I think. Sciclone is a great buy right now..year 2000 revenues will be between $17 to $20 million if not more...growing at over 100%/year..and the company's market cap is only $200 million. Today was just normal stock trading, some large buyers wanted to get filled below $9.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News